#Lenzilumab

Interesting preprint of the #LIVEAIR study of #lenzilumab in #COVID19:-double blind RCT n=502 hospitalized pts on suppl O2-lenzilumab associated with improved survival w/o ventilation: 84% vs 77.9% -larger benefit when

CRS management algorithm (adults) via @MDAndersonNews. This may be applicable to COVID19. https://www.mdanderson.org/documents/for-physicians/algorithms/clinical-management/clin-management-cytokine-release-web-algorithm.pdf Pediatric version. https:/

Last week, researchers published a preprint containing data about lenzilumab, a drug $HGEN is developing to prevent Covid patients from ending up on ventilators.Preprint here: https://www.medrxiv.org/content/10.1101/2021.05.01.21256470v1.fu